(Q36537922)

14 August 2017

1 reference

title

Detection of tumor antigens with monoclonal antibodies: immunopathology and immunodiagnosis (English)

1 reference

14 August 2017

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

28 October 2022

author name string

A. M. Neville

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684511

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1684511

28 October 2022

publication date

1 October 1991

1 reference

full work available at URL

14 August 2017

https://api.elsevier.com/content/article/PII:095279159190095I?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

https://api.elsevier.com/content/article/PII:095279159190095I?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Current Opinion in Immunology

28 October 2022

published in

1 reference

14 August 2017

3

1 reference

14 August 2017

5

1 reference

14 August 2017

674-678

1 reference

CA72-4: a new tumour marker for gastric cancer

14 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction

28 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Detection of occult nodal metastases in patients with colorectal carcinoma

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological conditions

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

A panel of antibodies useful in the cytologic diagnosis of metastatic melanoma

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Immunohistochemical analysis of human adenocarcinomas of the lung using the monoclonal antibody 44-3A6.

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Use of monoclonal antibodies to human breast-tumor-associated antigens in the diagnosis of fine-needle aspirates of breast nodules: results of a multicenter study

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Immunocytochemical characterization of lung tumors in fine-needle aspiration. The use of cytokeratin monoclonal antibodies for the differential diagnosis of squamous cell carcinoma and adenocarcinoma

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

A useful monoclonal antibody (BL2-10D1) to identify tumor cells in urine cytology

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas

28 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ

28 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas

28 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Potential value of hormone receptor assay in carcinoma in situ of breast

28 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human breast carcinomas

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit

28 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Expression of epidermal growth factor receptor in breast carcinoma

28 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia

28 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia

28 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0952-7915(91)90095-I

28 October 2022

Identifiers

1 reference

14 August 2017

1 reference